Department of Pharmacy, Howard University, USA
*Corresponding Author: Andre Jackson, Department of Pharmacy, Howard University, USA.
Received: February 25, 2022 Published: February 28, 2022
Generics have been on the market since the Waxman-Hatch bill was passed in 1984 and the approval process has worked well. However, there are new issues to be resolved. Among these are products with a delayed, sustained, long acting injections or complex absorption. Based upon these absorption issues, how well does adult data predict children. These areas are discussed in the commentary.
Keywords: Injections; Generics; Children/p>
Citation: Andre Jackson. “Considerations for Conducting Bioequivalence Studies on Complex Delayed-release, Long Acting Injections and Sustained-release Formulations". Acta Scientific Pharmacology 3.3 (2022): 57-58.
Copyright: © 2022 Andre Jackson. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.